| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/18/2008 | US20080229453 Expression vector comprising nucleotide sequences coding serine/threonine kinase for use in propagating transgenic planys with seeds comprising enhanced lipid and fatty acid storage |
| 09/18/2008 | US20080229452 Sugar and lipid metabolism regulators in plants II |
| 09/18/2008 | US20080229451 Expression of microbial proteins in plants for production of plants with improved properties |
| 09/18/2008 | US20080229449 Expression vector comprising nucleotide sequences coding insecticidal protein for use in propagating insect resistant crop plants; biological pest control |
| 09/18/2008 | US20080229439 Nucleic acid molecules and other molecules associated with transcription in plants and uses thereof for plant improvement |
| 09/18/2008 | US20080229438 Plasmid comprising nucleotide sequences coding human growth hormone for use in transformation and propagation in bovine embryos; bioreactors |
| 09/18/2008 | US20080227960 Crystallized estrogen receptor- beta (ER- beta ) complexed with genistein for use in designing modulators for treatment of cell proliferative disorders |
| 09/18/2008 | US20080227956 Novel morphogenic protein compositions of matter |
| 09/18/2008 | US20080227955 Nematode PAN and ZP Receptor-Like Sequences |
| 09/18/2008 | US20080227954 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive and nervous system disorders |
| 09/18/2008 | US20080227953 Myeloproliferative leukemia virus oncogene proteins for use in identifying modulators for prveention and treatment of blood disorders |
| 09/18/2008 | US20080227750 Complex of glycan and galactin accumulated on cell surfaces; therapy, prevention of autoimmune diseases |
| 09/18/2008 | US20080227745 Methods and compositions for soluble CPG15 |
| 09/18/2008 | US20080227740 Compositions and Methods for Elimination of Unwanted Cells |
| 09/18/2008 | US20080227739 Isolated polypeptide comprising amino acid sequence encoded by polynucleotide; physiologically acceptable carriers and immunostimulants |
| 09/18/2008 | US20080227737 Comprises nucleotide sequences for use as diagnostic tools in identifying allelic sequences associated with blood sugar defects |
| 09/18/2008 | US20080227734 Mutant Lrp5/6 Wnt-Signaling Receptors in Cancer Diagnosis, Prognosis, and Treatment |
| 09/18/2008 | US20080227719 administering to a patient an effective dosage of a polypeptide comprising an N-terminal segment of A beta , the segment beginning at residue 1-3 of A beta and ending at residues 7-11 of A beta to treat disease associated with amyloid deposit of A beta in the brain Alzheimer's disease, Down's syndrome |
| 09/18/2008 | US20080227718 administering to a patient an effective dosage of a polypeptide comprising an N-terminal segment of A beta , the segment beginning at residue 1-3 of A beta and ending at residues 7-11 of A beta to treat disease associated with amyloid deposit of A beta in the brain Alzheimer's disease, Down's syndrome |
| 09/18/2008 | US20080227715 Liquid composition of factor VII polypeptides |
| 09/18/2008 | US20080227713 amino acid sequence of Ser1-Pro2-Lys3-Met4-Val5-Gln6-Gly7-Ser8-Gly9-Cys10-Phe11-Gly12-Arg13-Lys14-Met15-Asp16-Arg17-Ile18-Ser19-Ser20-Ser21-Ser22-Gly23-Leu24-Gly25-Cys26-Lys27-Val28-Leu29-Arg30-Lys31-His32, either Met4, Met15, or both are oxidized; diagnosis heart failure |
| 09/18/2008 | US20080227712 Polypeptide for use in treatment and prevention of leukemia, hemophilia and nervous system disorders |
| 09/18/2008 | US20080227707 Bioactive peptides and unique ires elements from myelin proteolipid protein plp/dm20 |
| 09/18/2008 | US20080227706 Polypeptides and polynucleotides; genetic engineering; medical diagnosis; treatment of infection causes sepsis, meningitis, pneumonia, cellulitis, osteomyelitis, septic arthritis, endocarditis or epiglottis; bacterial protein antigen vaccine |
| 09/18/2008 | US20080227704 CXCL13 binding proteins |
| 09/18/2008 | US20080227703 neublastin neurotrophic factor polypeptides for treating neuropathy |
| 09/18/2008 | US20080227701 Antiangiogenic polypeptides and methods for inhibiting angiogenesis |
| 09/18/2008 | US20080227700 contacting the protein with a polypeptide up to about 50 amino acids in length having molecular chaperone activity; protein conformation disease is Alexander's disease, Alzheimer's disease, Creutzfeld-Jakob disease, Parkinson's disease, Huntington's disease, cataract, retinitis pigmentosa, prion disease |
| 09/18/2008 | US20080227699 Therapeutic Agent for Neurodegenerative Diseases |
| 09/18/2008 | US20080227698 oligopeptide antagonizes binding of DKK1 to LRP5 when in contact with LRP5; degenerative bone diseases |
| 09/18/2008 | US20080227697 Bacterial protein phosphoinositide probes and effectors |
| 09/18/2008 | US20080227695 reduced expression and/or function of Dlg (discs large) is an important factor for tumor formation; measuring the expression and/or function of Dlg |
| 09/18/2008 | US20080227694 Protein composed of sequence number 1 or 2; proteasome and polyubiquitin chain inhibitors; interaction with ZNF216 and/or AWP1 |
| 09/18/2008 | US20080227691 Blood Coagulation FVIII Analogues |
| 09/18/2008 | US20080227686 Novel Peptides that Promote Lipid Efflux |
| 09/18/2008 | US20080227683 Compounds Having Antitumor Activity |
| 09/18/2008 | US20080227659 Incrementally Truncated Nucleic Acids and Methods of Making Same |
| 09/18/2008 | US20080227650 Incrementally Truncated Nucleic Acids and Methods of Making Same |
| 09/18/2008 | US20080227205 Incorporation on Non-Naturally Encoded Amino Acids Into Proteins |
| 09/18/2008 | US20080227200 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and DNA coding for the same |
| 09/18/2008 | US20080227192 Nematode ATP Synthase Subunit E-Like Sequences |
| 09/18/2008 | US20080227178 Polypeptide factor from a thermophilic eubacterial species and use thereof in the production of functional, heterologous proteins in an expression host |
| 09/18/2008 | US20080227158 Novel polypeptide, novel dna and novel antibody |
| 09/18/2008 | US20080227157 Nucleic acids encoding fusion proteins based on ribosome-inactivating proteins of the mistletoe Viscum Album |
| 09/18/2008 | US20080227156 Nucleotide sequences coding myostatin epitopes for use in treatment and prevention of diabetic disorders; immunotherapy |
| 09/18/2008 | US20080227155 Pegylated soluble gp130-dimers useful as a medicament |
| 09/18/2008 | US20080227153 Site specific incorporation of keto amino acids into proteins |
| 09/18/2008 | US20080227152 In vivo incorporation of unnatural amino acids |
| 09/18/2008 | US20080227151 Method for simultaneous production of multiple proteins; vectors and cells for use therein |
| 09/18/2008 | US20080227149 Interferon-Alpha Polypeptides and Conjugates |
| 09/18/2008 | US20080227145 Filamentous Fungal Mutants With Improved Homologous Recombination Efficiency |
| 09/18/2008 | US20080227135 Autoimmune Conditions and NADPH Oxidase Defects |
| 09/18/2008 | US20080227131 P38 mitogen activated protein kinase fusion for use as reporter molecule in enzyme activation bioassays |
| 09/18/2008 | US20080227129 Using multimeric ubiquitin fusion protein as an enzyme activity indicator; destruction of reporter demonstrate enhanced enzyme activity |
| 09/18/2008 | US20080227127 Human NK3-Related Prostate Specific Gene-1 |
| 09/18/2008 | US20080227125 Using cardiovascular disorder plasma polypeptides (CPPs) as evaluative tools in detection coronary artery disease |
| 09/18/2008 | US20080227117 Antitrypsin peptide marker for use in diagnosis and treatment of chronic obstructive pulmonary disease |
| 09/18/2008 | US20080227110 Expression vector comprising nucleotide sequences coding human polypeptide for use in treatment of metabolic disorders; immunotherapy |
| 09/18/2008 | US20080227099 Assay for identifying modulators of cholesterol efflux; treating cardiovascular disorders |
| 09/18/2008 | US20080227097 Fluorescent protein and chromoprotein |
| 09/18/2008 | US20080227093 Membrane protein; point mutations; antibodies; food processing and bitterness; phenotype analysis |
| 09/18/2008 | US20080227082 Method of identifying a mhc class i restricted t cell response |
| 09/18/2008 | US20080226681 Highly Active Glycoproteins-Process Conditions and an Efficient Method for their Production |
| 09/18/2008 | US20080226679 Novel surface exposed proteins from chlamydia pneumoniae |
| 09/18/2008 | US20080226673 Subunit vaccine against respiratory syncytial virus infection |
| 09/18/2008 | US20080226666 Immunogenic polypeptide for protecting pigs against viral infection or postweaning multisystemic wasting syndrome |
| 09/18/2008 | US20080226665 EphA2 T-cell epitopes and uses therefor |
| 09/18/2008 | US20080226662 Nucleotide sequences coding mammalian immune system modulator (B7-DC) for use in treatment and prevention of viral infcetion a nd cell proliferative disorders; immunotherapy |
| 09/18/2008 | US20080226660 Nucleotide sequences coding human papilloma viral like particles (Hpv 58 L1) for use in designing vaccine for prevention virus associated cell proliferative disorders |
| 09/18/2008 | US20080226655 Kallikrein-Inhibitor Therapies |
| 09/18/2008 | US20080226654 Uses of mammalian cytokine; related reagents |
| 09/18/2008 | US20080226651 Envelope protein specific immunoglobulin for use in treatment and prevention human immunodeficieny virus infection |
| 09/18/2008 | US20080226647 Using interferon gamma receptor 1 (IFNGR1) specific immunoglobulin for diagnosis, prevention and treatment of myxovirus infection |
| 09/18/2008 | US20080226644 Nucleotide sequences coding breast cancer protein (BCMP 101) for use in developing vaccines and immunoglobulin which target and destroy tumor tissues; antitumor agents |
| 09/18/2008 | US20080226643 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/18/2008 | US20080226642 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 09/18/2008 | US20080226641 Mixture comprising group B streptococcal peptide for use in generating vaccine and immunoglobulins for diagnosis, prevention and treatment of urinary tract infections |
| 09/18/2008 | US20080226640 Mixture comprising serum complement system protein (INSP162) use in preparation of vaccines and antibodies for treatment and prevention of infcetion, cell proliferative, skin, neurodegenerative, bone, inflammatory, respiratory system and autoimmune disorders |
| 09/18/2008 | US20080226639 Heparin Binding Peptide |
| 09/18/2008 | US20080226637 Hemophilus polypeptide for generating immunoglobulins and vaccines for use in prevention and treatment of bacterial infection |
| 09/18/2008 | US20080226636 Novel human ulip/CRMP protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 09/18/2008 | US20080226633 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 09/18/2008 | US20080226631 Methods of modulating cytokine activity; related reagents |
| 09/18/2008 | US20080226623 Stabilized protein crystals, formulations comprising them and methods of making them |
| 09/18/2008 | US20080226620 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226610 Expression vector comprising nucleotide sequences coding syncytium-inducing polypeptide for use in targeting tumor cells for destruction; antitumor agents |
| 09/18/2008 | US20080226607 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226606 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226602 RNA viral vector for use in targeting tumor cell for destruction; antitumor agents and gene therapy |
| 09/18/2008 | US20080226598 Dendritc specific RNA viral plasmid comprising nucleotide sequences coding tumor associated for use in developing cancer vaccine; genetic vaccines |
| 09/18/2008 | US20080226597 Viricidal protein for prevention and treatment of hepatitis infection |
| 09/18/2008 | US20080226586 Expression vector comprising nucleotide sequences coding cytokine protein for diagnosis, prevention and treatment of thymus disorders |
| 09/18/2008 | US20080226565 Anticariogenic Proteins & Peptides & Saccharides |
| 09/18/2008 | US20080226563 Non-invasive localization of a light-emitting conjugate in a mammal |
| 09/18/2008 | US20080226560 Supplying cargo compound into cancer cells; cargo compound may be nucleic acids, Dna, Rna |
| 09/18/2008 | US20080226556 Using macrophages;milk fat globulins; epidermal growth factor mutants |
| 09/18/2008 | US20080224099 Carboxylic acid-modified edot for bioconjugation |
| 09/18/2008 | US20080223789 absorber material for filtration, purification, contains the hyperthermophilic ferritin which is biosynthesised from E. Coli strain; removing contaminants at very low concentrations |
| 09/18/2008 | CA2739530A1 Method of evaluating foam-holding property of fermented malt drink and marker for evaluating foam-holding |
| 09/18/2008 | CA2688121A1 Markers, antibodies and recombinant scfvs for mesenchymal stem cell-sub-populations and osteoclasts |